Is combined treatment more effective than switching to monotherapy in patients with resistant depression? A retrospective study

Neuroendocrinology Letters

Volumn 30, Issue 6, 2009, Pages 723-728

  Bares, Martin ^a,b   Novak, Tomas ^a,b   Kopecek, Miloslav ^a,b   Stopkova, Pavla ^a,b   Sos, Peter ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antidepressant monotherapy; Combined treatment; Resistant depression; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MONTGOMERY ASBERG DEPRESSION RATING SCALE; RETROSPECTIVE STUDY; SHORT FORM 36; TREATMENT RESPONSE;

EID: 77649245308     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders, 4th ed. Washington DC: American Psychiatric Press.
2. Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, et al (2008). Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol. 22:343-396.
3. Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, et al (2007). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. World J Biol Psychiatry. 8:67-104.
4. Beck AT, Rial WY, Rickels K (1974). Short form of depression inventory: cross-validation. Psychol Rep. 34: 1184-1186.
5. Beneke M, Rasmus W (1992). "Clinical Global Impression" (ECDEU): Some critical comments. Pharmacopsychiatry. 25: 171-176.
6. st ed. Arlington: American Psychiatric Publishing. p. 509-526.
7. Citrome L (2008). Compelling or irrelevant? Using number needed to treat can help decide. Acta Psychiatr Scand. 117: 412-419.
8. Fava M (2000). Management of nonresponse and intolerance: switching strategies. J Clin Psychiatry. 61 (suppl.2): 10-12.
9. Fava M (2003). Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 53:649-659.
10. Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, et al (2003). Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am. 26:457-494.
11. Guy W (1976). ECDEU assessment manual for psychopharmacology, revised 1976. National Institutes of Mental Health, Rockville, MD.
12. Jiang Q, Ahmed S (2009). An analysis of correlations among four outcome scales employed in clinical trials of patients with major depressive disorder. Ann Gen Psychiatry. 23:4.
13. Kessler RC, Berglund P, Demler O, Jin R, Merikanga KR, Walters EE (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 62:593-602.
14. Kobak KA, Greist, JJ, Jefferson, JW, Katzelnick DJ (1996). Computer-administered clinical rating scales: a review. Psychopharmacology. 127: 291-301.
15. Kobak KA, Skodol AE, Bender DS (2008). Diagnostic measure for adults. In: Rush JA, First MB, Blacker D, editors. Handbook of psychiatric measures. 2nd ed. Arlington: American Psychiatric Publishing, Inc. p.35-60.
16. Kopecek M, Cerná L, Sulak J, Raszka M, Bares M, Seifertová D (2007). Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy. Neuroendocrinol Lett. 28:889-894.
17. Marchiaro L, Rocca P, LeNoci F, Longo P, Montemagni C, Rigazzi C, et al (2005). Naturalistic, retrospective comparison between second-generation antipsychotics and depot neuroleptics in patients affected by schizophrenia. J Clin Psychiatry. 66: 1423-1431.
18. Montgomery SA, Åsberg M (1979). A new depression scale designed to be sensitive to change. Br J Psychiatry. 134: 382-389.
19. Nelson JC, Mazure CM, Jatlow PI, Bowers MB Jr, Price LH (2004). Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biol Psychiatry. 55:296-300.
20. Nemeroff CB (2007). Prevalence and management of treatment-resistant depression. J Clin Psychiatry. 68(Suppl. 8):17-25.
21. Nierenberg AA, Katz J, Fava M (2007). A critical overview of the pharmacologic management of treatment-resistant depression. Psychiatr Clin N Am. 30:13-29.
22. Posternak MA, Zimmerman M (2005). Is there a delay in the anti-depressant effect? A meta-analysis. J Clin Psychiatry. 66:148-158.
23. Pridmore S, Turnier-Shea Y, (2004). Medication options in the treatment of treatment-resistant depression. Aust N Z J Psychiatry. 38:219-225.
24. Rojo JE, Ros S, Agüera L, de la Gandara J, de Pedro JM (2005). Combined antidepressants: clinical experience. Acta Psychiatr Scand. 112(Suppl. 428): 25-31.
25. Rosenzweig-Lipson S, Beyer CE, Hughes ZA, Khawaja X, Rajarao SJ, Malberg JE, et al (2007). Differentiating antidepressants of the future: efficacy and safety. Pharmacol Ther. 113:134-153.
26. Ruhé HG, Dekker JJ, Peen J, Holman R, de Jonghe F (2005). Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores. Compr Psychiatry. 46:417-427.
27. Rush JA(2007). Limitations in efficacy of antidepressant monotherapy. J Clin Psychiatry.68(Suppl.10):8-10.
28. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D et al. (2006). Acute and long-term outcomes in depressed outpatients requiring one or several treatment steps: a Star*D report. Am J Psychiatry. 163: 1905-1917.
29. Sackeim HA (2001). The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 62:10-17.
30. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 59(Suppl. 20):22-33.
31. Shelton RC (2007). Augmentation strategies to increase antidepressant efficacy. J Clin Psychiatry. 68(Suppl 10):18-22.
32. Souery D, Amsterdam J, de Montigny C, Lecrubier Y, Montgomery S, Lipp O, et al (1999). Treatment resistant depression. Methodological overview and operational criteria. Eur Neuropsychopharmacol. 9:83-91.
33. Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, et al (2007). Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry. 68:1062-1070.
34. Stahl SM (2008). Antidepressants. In: Stahl S.M. Stahl's essential psychopharmacology. Neuroscientific basis and practical applications. 3rd ed. New York: Cambridge University Press, p. 511-666.
35. Thase ME, Rush AJ (1995). Treatment-resistant depression. In: Bloom FE, Kupfer Dj, editors. Psychopharmacoiogy: The Fourth Generation of Progress. New York: Raven Press Ltd. p. 1081-1097.
36. Thase ME, Rush AJ (1997). When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry. 58(Suppl. 13): 23-29.
37. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L et al (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 163:28-40.
38. Whyte EM, Basinski J, Farhi P, Dew MA, Begley A, Mulsant BH, et al (2004). Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry 65:1634-1641.
39. Zajecka J, Goldstein C (2005). Combining and augmenting: Choosing the right therapies for treatment-resistant depression. Psychiatric Annals. 35:993-1000.